Emergence in Spain of a Multidrug-Resistant Enterobacter cloacae Clinical Isolate Producing SFO-1 Extended-Spectrum β-Lactamase
- 1 March 2011
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 49 (3), 822-828
- https://doi.org/10.1128/jcm.01872-10
Abstract
Between February 2006 and October 2009, 38 patients in different wards at the A Coruña University Hospital (northwest Spain) were either infected with or colonized by an epidemic, multidrug-resistant (MDR), and extended-spectrum-β-lactamase (ESBL)-producing strain of Enterobacter cloacae (EbSF), which was susceptible only to carbapenems. Semiautomated repetitive extragenic palindromic sequence-based PCR (rep-PCR) and pulsed-field gel electrophoresis (PFGE) analysis revealed that all of the E. cloacae isolates belonged to the same clone. Cloning and sequencing enabled the detection of the SFO-1 ESBL in the epidemic strain and the description of its genetic environment. The presence of the ampR gene was detected upstream of bla SFO-1 , and two complete sequences of IS 26 surrounding ampR and ampA were detected. These IS 26 sequences are bordered by complete left and right inverted repeats (IRL and IRR, respectively), which suggested that they were functional. The whole segment flanked by two IS 26 copies may be considered a putative large composite transposon. A gene coding for aminoglycoside acetyltransferase (gentamicin resistance gene [ aac3 ]) was found downstream of the 3′ IS 26 . Despite the implementation of strict infection control measures, strain EbSF spread through different areas of the hospital. A case-control study was performed to assess risk factors for EbSF acquisition. A multivariate analysis revealed that the prior administration of β-lactam antibiotics, chronic renal failure, tracheostomy, and prior hospitalization were statistically associated with SFO-1-producing E. cloacae acquisition. This study describes for the first time an outbreak in which an SFO-1-producing E. cloacae strain was involved. Note that so far, this β-lactamase has previously been isolated in only a single case of E. cloacae infection in Japan.Keywords
This publication has 42 references indexed in Scilit:
- Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Enterobacter cloacae : Role of Carbapenem TherapyAntimicrobial Agents and Chemotherapy, 2010
- Meningitis Caused by Escherichia coli Producing TEM-52 Extended-Spectrum β-Lactamase within an Extensive Outbreak in a Neonatal Ward: Epidemiological Investigation and Characterization of the StrainJournal of Clinical Microbiology, 2010
- Using a Commercial DiversiLab Semiautomated Repetitive Sequence-Based PCR Typing Technique for Identification of Escherichia coli Clone ST131 Producing CTX-M-15Journal of Clinical Microbiology, 2009
- AmpC β-LactamasesClinical Microbiology Reviews, 2009
- Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase- Producing Escherichia coli : Risk Factors for Inadequate Initial Antimicrobial TherapyAntimicrobial Agents and Chemotherapy, 2008
- Complete Nucleotide Sequence of the pCTX-M3 Plasmid and Its Involvement in Spread of the Extended-Spectrum β-Lactamase GeneblaCTX-M-3Antimicrobial Agents and Chemotherapy, 2007
- Nosocomial Outbreak Due to Extended-Spectrum-Beta-Lactamase- Producing Enterobacter cloacae in a Cardiothoracic Intensive Care UnitJournal of Clinical Microbiology, 2007
- Characterization of a Large Outbreak by CTX-M-1-Producing Klebsiella pneumoniae and Mechanisms Leading to In Vivo Carbapenem Resistance DevelopmentJournal of Clinical Microbiology, 2006
- Enterobacter cloacaeOutbreak and Emergence of Quinolone Resistance Gene in Dutch HospitalEmerging Infectious Diseases, 2006
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001